You have 10 free articles left this month. Get your freeBasic subscription now and gain instant access to more.

Bosnian drug maker Bosnalijek turns to profit in H1

Bosnian drug maker Bosnalijek turns to profit in H1

SARAJEVO (Bosnia and Herzegovina), September 4 (SeeNews) – Bosnian pharmaceuticals maker Bosnalijek [SAJ:BSNLR] turned to a net profit of 4.55 million marka ($3.1 million/2.33 million euro) in the first half of 2014 from a net loss of 668,000 marka a year earlier, company data indicated.

Sales revenues rose 11.98% to 51.4 million marka through June, Bosnalijek said on its website.

(1 euro=1.95583 Bosnian marka)

Compare